Real-world faricimab switch in France: artificial intelligence-based detection of changes in exudative signs in difficult-to-treat neovascular age-related macular degeneration
Purpose Some patients with neovascular age-related macular degeneration (nAMD) have persistent signs of exudation under treatment with intravitreal injections of anti-vascular endothelial growth factor (VEGF) agents. We examined the real-world anatomical responses among patients with suboptimal resp...
Saved in:
| Main Authors: | Catherine Creuzot-Garcher, Pierre-Henry Gabrielle, Ali Erginay, Aude Couturier, Vincent Soler, Vincent Gualino, Charles Sohier, Maxime Sibert, Fanny Varenne, Jacqueline Butterworth |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-06-01
|
| Series: | BMJ Open Ophthalmology |
| Online Access: | https://bmjophth.bmj.com/content/10/1/e002267.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Faricimab in the Treatment of Exudative Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Italy: The FARIT Real World Study
by: Marco Lupidi, et al.
Published: (2025-07-01) -
Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration
by: Hang A, et al.
Published: (2024-12-01) -
Re: Patel et al: Oral Antithrombotic Medication Is Associated with Improved Visual Acuity Outcomes in Eyes with Neovascular Age-Related Macular Degeneration
by: Pierre-Henry Gabrielle, MD, PhD, et al.
Published: (2025-11-01) -
Retinal sensitivity above macular neovascularization under anti-VEGF therapy in exudative neovascular age-related macular degeneration
by: Laurenz Pauleikhoff, et al.
Published: (2025-03-01) -
Faricimab versus the standard of care for neovascular age-related macular degeneration in Italy: an indirect treatment comparison
by: Carlotta Galeone, et al.
Published: (2024-12-01)